Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016, Article ID 2148129, 8 pages
http://dx.doi.org/10.1155/2016/2148129
Review Article

How Does Interleukin-22 Mediate Liver Regeneration and Prevent Injury and Fibrosis?

1Cell & Molecular Biology Lab, Department of Zoology, University of the Punjab, Lahore, Pakistan
2Centennial College, Scarborough, Toronto, ON, Canada

Received 29 August 2016; Revised 13 October 2016; Accepted 25 October 2016

Academic Editor: Ethan M. Shevach

Copyright © 2016 Muhammad Babar Khawar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Dumoutier, J. Louahed, and J.-C. Renauld, “Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9,” Journal of Immunology, vol. 164, no. 4, pp. 1814–1819, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. G. F. Sonnenberg, L. A. Fouser, and D. Artis, “Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22,” Nature Immunology, vol. 12, no. 5, pp. 383–390, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Wolk, E. Witte, K. Witte, K. Warszawska, and R. Sabat, “Biology of interleukin-22,” Seminars in Immunopathology, vol. 32, no. 1, pp. 17–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Rutz, C. Eidenschenk, and W. Ouyang, “IL-22, not simply a Th17 cytokine,” Immunological Reviews, vol. 252, no. 1, pp. 116–132, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Wolk, E. Witte, U. Reineke et al., “Is there an interaction between interleukin-10 and interleukin-22?” Genes and Immunity, vol. 6, no. 1, pp. 8–18, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. L. A. Zenewicz, G. D. Yancopoulos, D. M. Valenzuela, A. J. Murphy, M. Karow, and R. A. Flavell, “Interleukin-22 but Not Interleukin-17 Provides Protection to Hepatocytes during Acute Liver Inflammation,” Immunity, vol. 27, no. 4, pp. 647–659, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Dumoutier, E. Van Roost, G. Ameye, L. Michaux, and J.-C. Renauld, “IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes,” Genes and Immunity, vol. 1, no. 8, pp. 488–494, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Dumoutier, E. Van Roost, D. Colau, and J.-C. Renauld, “Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 18, pp. 10144–10149, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Lafdil, A. M. Miller, S. H. Ki, and B. Gao, “Th17 cells and their associated cytokines in liver diseases,” Cellular & Molecular Immunology, vol. 7, no. 4, pp. 250–254, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Wolk, S. Kunz, E. Witte, M. Friedrich, K. Asadullah, and R. Sabat, “IL-22 increases the innate immunity of tissues,” Immunity, vol. 21, no. 2, pp. 241–254, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Boniface, F.-X. Bernard, M. Garcia, A. L. Gurney, J.-C. Lecron, and F. Morel, “IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes,” The Journal of Immunology, vol. 174, no. 6, pp. 3695–3702, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. S. C. Liang, X.-Y. Tan, D. P. Luxenberg et al., “Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides,” The Journal of Experimental Medicine, vol. 203, no. 10, pp. 2271–2279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. H.-L. Ma, S. Liang, J. Li et al., “IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation,” The Journal of Clinical Investigation, vol. 118, no. 2, pp. 597–607, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. M. Sa, P. A. Valdez, J. Wu et al., “The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis,” The Journal of Immunology, vol. 178, no. 4, pp. 2229–2240, 2007. View at Publisher · View at Google Scholar
  15. K. Wolk, E. Witte, E. Wallace et al., “IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis,” European Journal of Immunology, vol. 36, no. 5, pp. 1309–1323, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Wolk, H. S. Haugen, W. Xu et al., “IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not,” Journal of Molecular Medicine, vol. 87, no. 5, pp. 523–536, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Zheng, D. M. Danilenko, P. Valdez et al., “Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis,” Nature, vol. 445, no. 7128, pp. 648–651, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Andoh, Z. Zhang, O. Inatomi et al., “Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts,” Gastroenterology, vol. 129, no. 3, pp. 969–984, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Ikeuchi, T. Kuroiwa, N. Hiramatsu et al., “Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine,” Arthritis & Rheumatism, vol. 52, no. 4, pp. 1037–1046, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Radaeva, R. Sun, H.-N. Pan, F. Hong, and B. Gao, “Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation,” Hepatology, vol. 39, no. 5, pp. 1332–1342, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. S. H. Ki, O. Park, M. Zheng et al., “Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3,” Hepatology (Baltimore, Md.), vol. 52, no. 4, pp. 1291–1300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Ren, B. Hu, and L. M. Colletti, “IL-22 is involved in liver regeneration after hepatectomy,” American Journal of Physiology–Gastrointestinal and Liver Physiology, vol. 298, no. 1, pp. G74–G80, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Yang, Y. Zhang, L. Wang et al., “Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22,” Journal of Hepatology, vol. 53, no. 2, pp. 339–347, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. C.-X. Pan, J. Tang, X.-Y. Wang, F.-R. Wu, J.-F. Ge, and F.-H. Chen, “Role of interleukin-22 in liver diseases,” Inflammation Research, vol. 63, no. 7, pp. 519–525, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Geboes, L. Dumoutier, H. Kelchtermans et al., “Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice,” Arthritis & Rheumatism, vol. 60, no. 2, pp. 390–395, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Jiang, Z. Tan, L. Deng et al., “Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3,” Hepatology, vol. 54, no. 3, pp. 900–909, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Muñoz, M. M. Heimesaat, K. Danker et al., “Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17,” The Journal of Experimental Medicine, vol. 206, no. 13, pp. 3047–3059, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Zhao, Z. Zhang, Y. Luan et al., “Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment,” Hepatology, vol. 59, no. 4, pp. 1331–1342, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. G. K. Michalopoulos, “Liver regeneration: alternative epithelial pathways,” The International Journal of Biochemistry and Cell Biology, vol. 43, no. 2, pp. 173–179, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Turner, O. Lozoya, Y. Wang et al., “Human hepatic stem cell and maturational liver lineage biology,” Hepatology, vol. 53, no. 3, pp. 1035–1045, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Roskams, A. Katoonizadeh, and M. Komuta, “Hepatic progenitor cells: an update,” Clinics in Liver Disease, vol. 14, no. 4, pp. 705–718, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. C. B. Rountree, L. Mishra, and H. Willenbring, “Stem cells in liver diseases and cancer: recent advances on the path to new therapies,” Hepatology, vol. 55, no. 1, pp. 298–306, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. A. S. H. Gouw, A. D. Clouston, and N. D. Theise, “Ductular reactions in human liver: diversity at the interface,” Hepatology, vol. 54, no. 5, pp. 1853–1863, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Tanaka, T. Itoh, N. Tanimizu, and A. Miyajima, “Liver stem/progenitor cells: their characteristics and regulatory mechanisms,” Journal of Biochemistry, vol. 149, no. 3, pp. 231–239, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. P. J. Chestovich, Y. Uchida, W. Chang et al., “Interleukin-22: implications for liver ischemia-reperfusion injury,” Transplantation, vol. 93, no. 5, pp. 485–492, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Mastelic, A. P. F. do Rosario, M. Veldhoen et al., “IL-22 protects against liver pathology and lethality of an experimental blood-stage malaria infection,” Frontiers in Immunology, vol. 3, Article ID Article 85, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Pan, F. Hong, S. Radaeva, and B. Gao, “Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3,” Cellular & Molecular Immunology, vol. 1, no. 1, pp. 43–49, 2004. View at Google Scholar · View at Scopus
  38. O. Park, H. Wang, H. Weng et al., “In vivo consequences of liver-specific interleukin-22 expression in mice: implications for human liver disease progression,” Hepatology, vol. 54, no. 1, pp. 252–261, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. W.-W. Xing, M.-J. Zou, S. Liu et al., “Hepatoprotective effects of IL-22 on fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide in mice,” Cytokine, vol. 56, no. 2, pp. 174–179, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. W.-W. Xing, M.-J. Zou, S. Liu, T. Xu, J.-X. Wang, and D.-G. Xu, “Interleukin-22 protects against acute alcohol-induced hepatotoxicity in mice,” Bioscience, Biotechnology and Biochemistry, vol. 75, no. 7, pp. 1290–1294, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Feng, X. Kong, H. Weng et al., “Interleukin-22 promotes proliferation of liver stem/progenitor cells in mice and patients with chronic hepatitis B virus infection,” Gastroenterology, vol. 143, no. 1, pp. 188.e7–198.e7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Dambacher, F. Beigel, K. Zitzmann et al., “The role of interleukin-22 in hepatitis C virus infection,” Cytokine, vol. 41, no. 3, pp. 209–216, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Zhang, M. A. Cobleigh, J.-Q. Lian et al., “A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus,” Gastroenterology, vol. 141, no. 5, pp. 1897–1906, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. X. Kong, D. Feng, S. Mathews, and B. Gao, “Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease,” Journal of Gastroenterology and Hepatology, vol. 28, no. 1, pp. 56–60, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. D. Lejeune, L. Dumoutier, S. Constantinescu, W. Kruijer, J. J. Schuringa, and J.-C. Renauld, “Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line: pathways that are shared with and distinct from IL-10,” The Journal of Biological Chemistry, vol. 277, no. 37, pp. 33676–33682, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. B. Gao, “Cytokines, STATs and liver disease,” Cellular & molecular immunology, vol. 2, no. 2, pp. 92–100, 2005. View at Google Scholar · View at Scopus
  47. E. Witte, K. Witte, K. Warszawska, R. Sabat, and K. Wolk, “Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection,” Cytokine & Growth Factor Reviews, vol. 21, no. 5, pp. 365–379, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. L. A. Zenewicz and R. A. Flavell, “Recent advances in IL-22 biology,” International Immunology, vol. 23, no. 3, pp. 159–163, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. B. Gao, “Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease,” Journal of Gastroenterology and Hepatology, vol. 27, no. s2, pp. 89–93, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. M. S. Wilson, C. G. Feng, D. L. Barber et al., “Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections,” The Journal of Immunology, vol. 184, no. 8, pp. 4378–4390, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. B. Kronenberger, I. Rudloff, M. Bachmann et al., “Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study,” BMC Medicine, vol. 10, article 102, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. S. C. Liang, C. Nickerson-Nutter, D. D. Pittman et al., “IL-22 induces an acute-phase response,” The Journal of Immunology, vol. 185, no. 9, pp. 5531–5538, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. K. Kakimi, T. E. Lane, S. Wieland et al., “Blocking chemokine responsive to γ-2/interferon (IFN)-γ inducible protein and monokine induced by IFN-γ activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes,” Journal of Experimental Medicine, vol. 194, no. 12, pp. 1755–1766, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. G. Sitia, M. Isogawa, M. Iannacone, I. L. Campbell, F. V. Chisari, and L. G. Guidotti, “MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs,” The Journal of Clinical Investigation, vol. 113, no. 8, pp. 1158–1167, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Eyerich, K. Eyerich, D. Pennino et al., “Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling,” The Journal of Clinical Investigation, vol. 119, no. 12, pp. 3573–3585, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Sertorio, X. Hou, R. F. Carmo et al., “IL-22 and IL-22 binding protein (IL-22BP) regulate fibrosis and cirrhosis in hepatitis C virus and schistosome infections,” Hepatology, vol. 61, no. 4, pp. 1321–1331, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Stange, M. R. Hepworth, S. Rausch et al., “IL-22 mediates host defense against an intestinal intracellular parasite in the absence of IFN-γ at the cost of Th17-driven iImmunopathology,” The Journal of Immunology, vol. 188, no. 5, pp. 2410–2418, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. L. Dumoutier, D. Lejeune, D. Colau, and J.-C. Renauld, “Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22,” The Journal of Immunology, vol. 166, no. 12, pp. 7090–7095, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. S. V. Kotenko, L. S. Izotova, O. V. Mirochnitchenko et al., “Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity,” The Journal of Immunology, vol. 166, no. 12, pp. 7096–7103, 2001. View at Publisher · View at Google Scholar · View at Scopus
  60. W. Xu, S. R. Presnell, J. Parrish-Novak et al., “A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 17, pp. 9511–9516, 2001. View at Publisher · View at Google Scholar · View at Scopus
  61. B. H. Gruenberg, A. Schoenemeyer, B. Weiss et al., “A novel, soluble homologue of the human IL-10 receptor with preferential expression in placenta,” Genes and Immunity, vol. 2, no. 6, pp. 329–334, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. B. Weiss, K. Wolk, B. H. Grünberg et al., “Cloning of murine IL-22 receptor alpha 2 and comparison with its human counterpart,” Genes and Immunity, vol. 5, no. 5, pp. 330–336, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. C.-C. Wei, T.-W. Ho, W.-G. Liang, G.-Y. Chen, and M.-S. Chang, “Cloning and characterization of mouse IL-22 binding protein,” Genes and Immunity, vol. 4, no. 3, pp. 204–211, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. N. J. Logsdon, B. C. Jones, K. Josephson, J. Cook, and M. R. Walter, “Comparison of interleukin-22 and interleukin-10 soluble receptor complexes,” Journal of Interferon & Cytokine Research, vol. 22, no. 11, pp. 1099–1112, 2002. View at Publisher · View at Google Scholar · View at Scopus
  65. K. Wolk, E. Witte, U. Hoffmann et al., “IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease,” The Journal of Immunology, vol. 178, no. 9, pp. 5973–5981, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. P. R. de Moura, L. Watanabe, L. Bleicher et al., “Crystal structure of a soluble decoy receptor IL-22BP bound to interleukin-22,” FEBS Letters, vol. 583, no. 7, pp. 1072–1077, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. K. Sugimoto, A. Ogawa, E. Mizoguchi et al., “IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis,” The Journal of Clinical Investigation, vol. 118, no. 2, pp. 534–544, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. B. C. Jones, N. J. Logsdon, and M. R. Walter, “Structure of IL-22 bound to its high-affinity IL-22R1 chain,” Structure, vol. 16, no. 9, pp. 1333–1344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. J. C. Martin, G. Bériou, M. Heslan et al., “Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid,” Mucosal Immunology, vol. 7, no. 1, pp. 101–113, 2014. View at Publisher · View at Google Scholar · View at Scopus
  70. Y.-S. Lee and W.-I. Jeong, “Retinoic acids and hepatic stellate cells in liver disease,” Journal of Gastroenterology and Hepatology, vol. 27, no. 2, pp. 75–79, 2012. View at Publisher · View at Google Scholar · View at Scopus